Researchers developed a blood test that spots ALS with 90% accuracy. The 46-gene panel could cut diagnostic delays that now ...
Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term imaging and plasma data show that obese individuals experience much faster ...
Using machine learning models, researchers at Michigan Medicine have identified a potential way to diagnose amyotrophic ...
LANSING, Mich. (WLNS) – An experimental drug could help improve movement for patients with spinal cord injuries. Larry Williams broke his neck in a cycling accident three years ago, and, wanting his ...
Wellness Wednesday: New drug aims to improve movement post-spinal cord injuries Gretchen Carlson Spills Why Trump's 'Piggy' Attack Strikes Her 'At The Core' The U.S. just minted its final penny—why ...
Scientists studying an existing blood pressure drug called hydralazine accidentally discovered that it could potentially fight cancer. Hydralazine has been used to treat high blood pressure since the ...
A Penn-led team has revealed how hydralazine, one of the world's oldest blood pressure drugs and a mainstay treatment for preeclampsia, works at the molecular level. In doing so, they made a ...
This article originally appeared on The Conversation. A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug Administration because it ...
An experimental drug could help improve movement for patients with spinal cord injuries, and it's already making a big difference for one patient in Bensalem, Pennsylvania. Larry Williams is walking, ...
(NEXSTAR) – Nearly 590,000 bottles of blood pressure drugs have been recalled over concerns that they may contain a potentially carcinogenic chemical that exceeds the “acceptable intake limit.” The ...
The U.S. Food and Drug Administration says drugmakers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a ...